ConductScience.org, home

Comparison · NCT04296396-3a5791ba

Individualized Opioid Prescription (IOPP) -Neonates/Infants vs Fixed Opioid Prescription - Neonates/Infants: Infant Hospital Readmissions

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Individualized Opioid Prescription (IOPP) -Neonates/Infants vs Fixed Opioid Prescription - Neonates/Infants: Infant Hospital Readmissions. Trial comparisons, record NCT04296396-3a5791ba. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04296396-3a5791ba

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.02140.01660.0275wilson
Risk in group 20.02260.01770.0288wilson
Risk difference, group 1 minus group 2-0.00113-0.008960.00669newcombe hybrid score
Risk ratio, group 1 over group 20.950.6691.35log
Odds ratio, group 1 over group 20.9490.6621.36log
Number needed to treat, for one fewer participant with the outcome on Individualized Opioid Prescription (IOPP) -Neonates/Infants than on Fixed Opioid Prescription - Neonates/Infants883from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Individualized Opioid Prescription (IOPP) -Neonates/InfantsNeonates/infants of participants in the Individualized opioid prescription protocol (IOPP) with shared decision making group.592,754OG000
Group 2Fixed Opioid Prescription - Neonates/InfantsNeonates/infants of participants in the fixed opioid prescription group.632,793OG001

Outcome

Type
SECONDARY
Title
Infant Hospital Readmissions
Description
Proportion of infants readmitted to the hospital
Time frame
6 weeks postpartum
Population
2856 and 2889. Data is missing for 102 neonates in the IOPP group and 92 neonates in the fixed opioid group.

Source ClinicalTrials.gov

Trial

Title
Opioid Prescription After Cesarean Trial
NCT number
NCT04296396
Phases
PHASE3
Conditions
Pregnancy Related, Opioid Use, Pain
Interventions
0 to 20 tablets of oxycodone 5mg, Fixed opioid prescription
Lead sponsor
The George Washington University Biostatistics Center
Results first posted
2023-10-03

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04296396-3a5791ba